Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 37 for “"Autoreactive B cells"”.
-
Autoreactive B Cells in ANCA-Associated Vasculitis
… in their pathogenesis. We aimed to investigate autoreactive proteinase 3 (PR3+) B cells involved in the development of human AAV. We previously developed a customized flow-cytometry method to identify autoreactive B cells among cryopreserved peripheral blood mononuclear cells (PBMC), using …
-
Golgi Specificity and Development of Autoreactive B Cells
… bound DNA very well. How did these anti-DNA B cells escape central tolerance? In our effort to answer this puzzle, we discovered that receptors with the Vk38c light chain may have specificity to a Golgi antigen in addition to DNA. This suggested that such anti-DNA receptors may bind to an …
-
Antigen-specific targeting of autoreactive B-cells in Rheumatoid Arthritis
B-cells are a crucial part of the immune system. They recognize antigens through their B-cell receptor (BCR) and produce antibodies against them. In Rheumatoid Arthritis (RA), some B-cells mistakenly target self-antigens like citrullinated peptides, leading to joint inflammation and bone erosion. …
-
Chemical Strategies for Antigen-Selective Targeting of Autoreactive B Cells
Contains fulltext : 202990.pdf (Publisher’s version ) (Open Access)
-
From Molecules to Cells: Strategies to Target and Eliminate Autoreactive B-cells
… role in this process, in particular when these cells respond to what is known as ‘citrullinated proteins’. Normal treatments suppress the entire immune system or kill all B cells, including the good ones. In this study, we looked at how we can target only the ‘faulty’ B cells using CCP4, a …
-
TLR7-dependent and -independent responses of autoreactive B cells to nucleic acid containing immune complexes
… and ribonucleoproteins. The activation of autoreactive B cells by DNA- or RNA-containing antigens is dependent on Toll-like receptor (TLR)9 and TLR7, respectively. Importantly, TLR7, but not TLR9, is required for the pathogenesis of murine models of SLE. Here we dissect the activation of …
-
AUTOANTIBODIES AND AUTOREACTIVE B CELLS IN THE BONE MARROW AND THE PERIPHERAL BLOOD OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA
… platelet production. In addition, detecting autoreactive antibody-secreting B cells using the Enzyme-linked Immunospot (ELISPOT) assay was shown to be highly sensitive. In this study, the bone marrow and the peripheral blood compartments of ITP patients were tested for the presence of …
-
Roles of Igh Intronic Enhancer Eμ in Clonal Selection at the Pre-B to Immature B Cell Transition and in the Elimination of Autoreactive B Cells
… at half of the wild-type levels in pre-B cells. We also described an Eμ-dependent "check-point", operating at the pre-B to immature B cell transition, for heavy chain allelic exclusion. We now show that deletion of Eμ results in a smaller immature B cell compartment, and the pre-BCR/BCR …
-
Changes in autoreactive B cell lifestyle early in development of autoimmunity
… by destruction of the pancreatic beta cells, leading to decreased production of insulin and hyperglycemia. Although environmental factors contribute, genetic factors are likely the primary determinants of risk. With recent advances in GWAS studies, hundreds of risk-conferring alleles …
-
Investigating the origins of IgG1 pan-neurofascin antibodies in a severe subtype of autoimmune neuropathy
… understand the origins and regulation of the autoreactive B-cell responses in this disease.<br><br>In this thesis, I developed and applied a suite of immunological tools to dissect the neurofascin-specific B-cell response in pan-NF AN. A peripheral blood mononuclear cell (PBMC) culture system …
-
T Cell Molecular Mechanisms in the Pathogenesis of Systemic Lupus Erythematosus
… women. Most therapies have focused on targeting autoreactive B cells; yet, in the past 60 years, only one B cell therapy met trial endpoints, with modest efficacy. Lupus treatment still relies on broad immunosuppression, increasing infection risk. Selective therapies are needed to target the most …
-
Chimeric Autoantibody Receptor T Cells For Targeted Depletion Of Myeloperoxidase-Specific Anti-Neutrophil Cytoplasmic Antibody-Producing B Cells
… MPO chimeric autoantibody receptor (CAAR) T cells as a target-specific therapy to eliminate MPO-autoreactive B cells. MPO CAAR T cells selectively eliminate anti-MPO BCR-expressing B cell lines in vitro and in vivo. In primary murine autoreactive B cell cultures, MPO CAAR T cells suppressed …
-
Integrin αvβ3 limits Toll-like receptor type I interferon production by plasmacytoid dendritic cells and restricts autoimmunity
Plasmacytoid dendritic cells (pDCs) are strongly implicated as a major source of type I interferon (IFN-I) in systemic lupus erythematosus (SLE), triggered through Toll-like receptor (TLR)-mediated recognition of nucleic acids released from dying cells. However, relatively little is known about how …
-
Gatekeepers of cytokine receptor signalling in the pathogenesis of systemic lupus erythematosus
… and interesting phenotypes were observed in B cells, especially the increase in immature and transitional 1 (T1) B cells, which can harbour cells with considerable levels of autoreactivity that can contribute to autoantibody production if tolerance is breached. An increase in the equivalent …
-
Interrogating the development of autoreactive B and antibody-secreting cells across neuroglial surface autoantibody-mediated conditions
… in rare but treatable neurological conditions. B cells are responsible for this antibody production; however, their origin and the pathogenicity of their secreted neuroglial-specific autoantibodies remain poorly understood. Little is known about how these autoreactive B-cells escape tolerance and …
-
Autophagy in Systemic Lupus Erythematosus
… of human and murine lupus, a disease in which B cells are critical effectors of pathology. Autophagy was assessed using multiple techniques in NZB/W and control mice, and in patients with SLE compared to healthy controls. I evaluated the phenotype of the B cell compartment in Vav-Atg7-/- mice in …
-
Characterization of a novel subpopulation of autoantibody-producing B-cells in human blood
Human peripheral B cells that co-express the surface B cell antigen receptor (BCR) and pre- BCR (V-preB+L+ B cells) represent about 0,5-1% of the peripheral B cell pool in healthy individuals but are significantly enriched in the joints of patients with rheumatoid arthritis (RA). To address the …
-
Decreased regulatory B cells in asthma associated with severity
… the development and activity of self-reactive cells, including those capable of producing autoantibodies. Lymphopenia can lead to skewed non-regulatory to regulatory lymphocyte subsets that support a microenvironment with reduced ability to limit self-reactivity. In this study, wanted to …
-
The role of connexin 43 in B cell receptor signaling and the high throughput screen for novel B cell receptor signaling inhibitors
B cells migrate throughout the body, following chemokine gradients, to search for foreign antigens. When a B cell encounters an antigen-presenting cell (APC) bearing antigens that bind its B cell receptors (BCRs), it spreads across the surface of the APC to scan for additional antigens. This …
-
Development of Autoantigen Drug Constructs for Precise Epitope Targeting in Type 1 Diabetes
… immune response targeting insulin-producing beta cells in the pancreas. Insulin and other affiliated pancreatic autoantigens have been identified as key players in disease pathogenesis. While the exact mechanism of action contributing to disease is unknown, the role of islet-antigen specific …
Page 1 of 2